Regulus Therapeutics Inc RGLS Valuation Ratios and Share Stats

S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Regulus Therapeutics Inc (RGLS)
Regulus Therapeutics Inc (RGLS) Financials

Regulus Therapeutics Inc (RGLS)

1.62

0.00

(0.00%)

Closed 18 December 8:00AM

Delayed by 15 minutes

0.00

0.00

(0.00%)

After Hours: -

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-67.705	-80.579	-92.133	-53.114	-39.48	-52.439	-49.185	-77.549
Return on Equity (%)	-90.852	-157.529	-331.783	-262.58	-68.33	-68.675	-64.189	-110.272
Return on Invested Capital (%)	-81.721	-126.742	-328.517	-242.326	-61.552	-65.189	-60.926	-114.112
Operating Margin (%)	-6755.276	-96359.722	-64311.111	-240.925	-139.137	N/A	N/A	N/A
Net Profit Margin (%)	-6853.936	-99868.056	-67651.389	-272.131	-157.206	N/A	N/A	N/A
Book Value Per Share	1.04	0.331	-0.721	0.939	0.384	0.376	1.973	0.83
Earnings Per Share	-1.546	-0.692	-5.524	-0.885	-0.233	-0.191	-1.682	-1.179
Cash Per Share	0.282	0.13	1.58	1.623	0.461	0.414	1.439	0.933
Working Capital Per Share	1.392	0.328	-0.834	0.895	0.373	0.411	1.925	0.772
Operating Profit Per Share	0.023	0.001	0.008	0.325	0.148	N/A	N/A	N/A
EBIT Per Share	-1.546	-0.694	-5.517	-0.884	-0.233	-0.19	-1.682	-1.178
EBITDA Per Share	-1.546	-0.694	-5.517	-0.884	-0.233	-0.19	-1.682	-1.178
Free Cash Flow Per Share	-1.571	-0.713	-5.778	-0.917	-0.24	-0.192	-1.668	-1.163

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	52.93M	103.96M	8.82M	21.02M	67.43M	145.97M	16.84M	N/A

Key Stats and Ratios

Year End 31 December 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	16.84M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	106.11M
Price to Earnings Ratio	-3.53
Price to Sales Ratio	0
Price to Cash Ratio	4.46
Price to Book Ratio	5.01
Dividend Yield	-

Share Statistics

Shares Outstanding	65.5M
Average Volume (1 week)	336.97k
Average Volume (1 Month)	255.04k
52 Week Change	20.00%
52 Week High	3.78
52 Week Low	1.08

More Ratios Coming Soon!

Regulus Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions